Sources

11 Total Sources

OpenAI Buys $20 Million-Funded Orchestra Bio to Expand Rosalind for Drug Research

Left40%

Center60%

TechCrunch1h ago

OpenAI Acquires Orchestra Bio to Boost Biotech AI Research

OpenAI acquires Orchestra Bio to connect research AI with drug-development operations : r/OpenAI

Securities.io7h ago

OpenAI Buys Orchestra Bio to Build Drug Development Agents – Securities.io

Exclusive: OpenAI has acquired Orchestra Bio

OpenAI acquires Orchestra Bio to expand life sciences AI operations

OpenAI Acquires Orchestra Bio to Boost AI in Drug Development

Polymarket on X: "JUST IN: OpenAI acquires biotech AI startup Orchestra Bio, accelerating its push into AI-driven drug discovery." / X

Investing.com22h ago

OpenAI acquires Orchestra Bio to boost drug development AI, Axios reports By Investing.com

Investing.com Australia22h ago

OpenAI acquires Orchestra Bio to boost drug development AI, Axios reports By Investing.com

Yahoo Finance22h ago

Exclusive: OpenAI has acquired Orchestra Bio

Introducing GPT-Rosalind for life sciences research | OpenAI